Relmada Therapeutics (RLMD) Non Operating Income (2014 - 2026)
Relmada Therapeutics' Non Operating Income was $2.1 million in Q2 2026, up 490.9% from $354,864 a year earlier and up 411.7% from the prior quarter.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Non Operating Income (2014 - 2026) Analysis & Trends
On a trailing twelve-month basis, Relmada Therapeutics' Non Operating Income was $3.21 million through Jun 30, 2026, up 18.1% year-over-year; for FY2025, it came in at $1.72 million, down 56.2% from FY2024.
- Non Operating Income shows a five-year compound annual growth rate of 4.4% (FY2020 to FY2025).
- In earlier years, Non Operating Income was $3.91 million in FY2024 (-20.3%), $4.91 million in FY2023 (+16.8%), $4.21 million in FY2022 and -$48,317 in FY2021.
- The Q2 2026 figure marks the highest quarterly Non Operating Income since Q2 2022.
- Compared with a year earlier, Non Operating Income was higher in three of the last eight quarters, with growth averaging 35.5%.
- The best year-over-year quarter for Non Operating Income over five years was Q2 2026 (growth of 490.9%); the worst was Q2 2023 (a decline of 87.0%).
- Per Business Quant data, RLMD's Non Operating Income in the three quarters before Q2 2026 was $409,798 (Q1 2026), $465,352 (Q4 2025) and $235,850 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Relmada Therapeutics | 402.15 Mn | 402.15 Mn | - | 2.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.10 Mn |
| Mar 31, 2026 | 409,798.00 |
| Dec 31, 2025 | 465,352.00 |
| Sep 30, 2025 | 235,850.00 |
| Jun 30, 2025 | 354,864.00 |
| Mar 31, 2025 | 658,970.00 |
| Dec 31, 2024 | 418,418.00 |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | 1.05 Mn |
| Mar 31, 2024 | 1.16 Mn |
| Dec 31, 2023 | 1.66 Mn |
| Sep 30, 2023 | 690,580.00 |
| Jun 30, 2023 | 723,772.00 |
| Mar 31, 2023 | 1.83 Mn |
| Dec 31, 2022 | 758,055.00 |
| Sep 30, 2022 | -681,546.00 |
| Jun 30, 2022 | 5.58 Mn |
| Mar 31, 2022 | -1.45 Mn |
| Dec 31, 2021 | -195,719.00 |
| Sep 30, 2021 | 47,444.00 |
API Access
Relmada Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();